Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Mar 13;12(6):2226. doi: 10.3390/jcm12062226

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Serum concentration of tIgE and mite sIgE/tIgE ratio in patients with AR, AS, AD, and their multimorbidities. (a) Serum concentration of tIgE in patients with AR+AS/CVA+AD/eczema was higher than AR+AS/CVA; Serum concentrations of tIgE of AR or AS/CVA were lower than their multimorbidities; Serum concentration of tIgE of AD/eczema was lower than AR and AR multimorbidities, and AR higher than AS/CVA. (b) D. pteronyssinus sIgE/tIgE ratio was higher in patients with upper airway allergic multimorbidities, such as AR co-occurring with AS/CVA or AD/eczema, and lower in patients only have AS/CVA or AD/eczema. The ratio in AR was higher than in AS/CVA or AD. (c) D. farinae sIgE/tIgE ratio pattern was similar to D. pteronyssinus. *: p < 0.05; **: p < 0.01; ***: p < 0.001.